Prospective study of military service and mortality from ALS

Neurology

Volumn 64, Issue 1, 2005, Pages 32-37

  Weisskopf, M G ^a   O'Reilly, E J ^a   McCullough, M L ^d   Calle, E E ^d   Thun, M J ^d   Cudkowicz, M ^c   Ascherio, A ^a,b  

^a HARVARD SCHOOL OF PUBLIC HEALTH   (United States)

^b BRIGHAM AND WOMEN S HOSPITAL   (United States)

^c MASSACHUSETTS GENERAL HOSPITAL   (United States)

^d AMERICAN CANCER SOCIETY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AIR FORCE; AMYOTROPHIC LATERAL SCLEROSIS; ARMY; ARTICLE; CANCER PREVENTION; COHORT ANALYSIS; FEMALE; FOLLOW UP; HUMAN; MALE; MANTEL HAENSZEL TEST; MILITARY SERVICE; MORTALITY; NON PROFIT ORGANIZATION; PRIORITY JOURNAL; PUERTO RICO; RISK ASSESSMENT; SOLDIER; UNITED STATES;

EID: 11444268046     PISSN: 00283878     EISSN: None     Source Type: Journal    
DOI: 10.1212/01.WNL.0000148649.17706.D9     Document Type: Article

References (45)

1. del Aguila MA, Longstreth WT Jr, McGuire V, Koepsell TD, van Belle G. Prognosis in amyotrophic lateral sclerosis: a population-based study. Neurology 2003;60:813-819.
2. Drory VE, Birnbaum M, Korczyn AD, Chapman J. Association of APOE epsilon4 allele with survival in amyotrophic lateral sclerosis. J Neurol Sci 2001;190:17-20.
3. Louwerse ES, Visser CE, Bossuyt PM, Weverling GJ. Amyotrophic lateral sclerosis: mortality risk during the course of the disease and prognostic factors. The Netherlands ALS Consortium. J Neurol Sci 1997;152(suppl 1):S10-S17.
4. Magnus T, Beck M, Giess R, Puls I, Naumann M, Toyka KV. Disease progression in amyotrophic lateral sclerosis: predictors of survival. Muscle Nerve 2002;25:709-714.
5. Sorenson EJ, Stalker AP, Kurland LT, Windebank AJ. Amyotrophic lateral sclerosis in Olmsted County, Minnesota, 1925 to 1998. Neurology 2002;59:280-282.
6. Walling AD. Amyotrophic lateral sclerosis: Lou Gehrig's disease. Am Fam Physician 1999;59:1489-1496.
7. Siddique T, Nijhawan D, Hentati A. Familial amyotrophic lateral sclerosis. J Neural Transm [Suppl] 1997;49:219-233.
8. Armon C. Motor neuron disease. In: Gorelick PB, Alter M, eds. Handbook of neuroepidemiology. New York: Dekker, 1994:407-456.
9. Haley RW. Excess incidence of ALS in young Gulf War veterans. Neurology 2003;61:750-756.
10. Horner RD, Kamins KG, Feussner JR, et al. Occurrence of amyotrophic lateral sclerosis among Gulf War veterans. Neurology 2003;61:742-749.
11. Armon C. Occurrence of amyotrophic lateral sclerosis among Gulf War veterans. Neurology 2004;62:1027-1029.
12. Rose MR. Gulf War service is an uncertain trigger for ALS. Neurology 2003;61:730-731.
13. Thun MJ, Calle EE, Rodriguez C, Wingo PA. Epidemiological research at the American Cancer Society. Cancer Epidemiol Biomarkers Prev 2000;9:861-868.
14. Calle EE, Terrell DD. Utility of the National Death Index for ascertainment of mortality among Cancer Prevention Study II participants. Am J Epidemiol 1993;137:235-241.
15. World Health Organization. International classification of diseases for oncology. 2nd ed. Geneva: World Health Organization, 1990.
16. Breslow NE, Day NE. Statistical methods in cancer res, vol 2: the design and analysis of cohort studies. New York: Oxford University Press, 1987:114.
17. Deapen DM, Henderson BE. A case-control study of amyotrophic lateral sclerosis. Am J Epidemiol 1986;123:790-799.
18. Granieri E, Carreras M, Tola R, et al. Motor neuron disease in the province of Ferrara, Italy, in 1964-1982. Neurology 1988;38:1604-1608.
19. Gunnarsson LG, Bodin L, Soderfeldt B, Axelson O. A case-control study of motor neurone disease: its relation to heritability, and occupational exposures, particularly to solvents. Br J Ind Med 1992;49:791-798.
20. Holloway SM, Mitchell JD. Motor neurone disease in the Lothian Region of Scotland 1961-81. J Epidemiol Community Health 1986;40:344-350.
21. McGuire V, Longstreth WT Jr, Nelson LM, et al. Occupational exposures and amyotrophic lateral sclerosis. A population-based case-control study. Am J Epidemiol 1997;145:1076-1088.
22. Rosati G, Pinna L, Granieri E, et al. Studies on epidemiological, clinical, and etiological aspects of ALS disease in Sardinia, Southern Italy. Acta Neurol Scand 1977;55:231-244.
23. Strickland D, Smith SA, Dolliff G, Goldman L, Roelofs RI. Amyotrophic lateral sclerosis and occupational history. A pilot case-control study. Arch Neurol 1996;53:730-733.
24. Haley RW, Hom J, Roland PS, et al. Evaluation of neurologic function in Gulf War veterans. A blinded case-control study. JAMA 1997;277:223-230.
25. Self-reported illness and health status among Gulf War veterans. A population-based study. The Iowa Persian Gulf Study Group. JAMA 1997;277:238-245.
26. Kang HK, Mahan CM, Lee KY, Magee CA, Murphy FM. Illnesses among United States veterans of the Gulf War: a population-based survey of 30,000 veterans. J Occup Environ Med 2000;42:491-501.
27. Kang HK, Mahan CM, Lee KY, et al. Evidence for a deployment-related Gulf War syndrome by factor analysis. Arch Environ Health 2002;57:61-68.
28. Smith TC, Gray GC, Knoke JD. Is systemic lupus erythematosus, amyotrophic lateral sclerosis, or fibromyalgia associated with Persian Gulf War service? An examination of Department of Defense hospitalization data. Am J Epidemiol 2000;151:1053-1059.
29. Brooks BR, Miller RG, Swash M, Munsat TL. El Escorial revisited: revised criteria for the diagnosis of amyotrophic lateral sclerosis. Amyotroph Lateral Scler 2000;1:293-299.
30. Buckley J, Warlow C, Smith P, Hilton-Jones D, Irvine S, Tew JR. Motor neuron disease in England and Wales, 1959-1979. J Neurol Neurosurg Psychiatry 1983;46:197-205.
31. Chio A, Magnani C, Oddenino E, Tolardo G, Schiffer D. Accuracy of death certificate diagnosis of amyotrophic lateral sclerosis. J Epidemiol Community Health 1992;46:517-518.
32. Hoffman PM, Brody JA. The reliability of death certificate reporting for amyotrophic lateral sclerosis. J Chronic Dis 1971;24:5-8.
33. O'Malley F, Dean G, Elian M. Multiple sclerosis and motor neurone disease: survival and how certified after death. J Epidemiol Community Health 1987;41:14-17.
34. Weisskopf MG, McCullough ML, Calle EE, Thun MJ, Cudkowicz M, Ascherio A. Prospective study of cigarette smoking and amyotrophic lateral sclerosis. Am J Epidemiol 2004;160:26-33.
35. Brantley LC, Hammond JR. Assessment of airborne exposures to lead during military vehicle finishing operations. Mil Med 1982;147:49-50.
36. Lofstedt H, Selden A, Storeus L, Bodin L. Blood lead in Swedish police officers. Am J Ind Med 1999;35:519-522.
37. Ozonoff D. Lead on the range. Lancet 1994;343:6-7.
38. Valway SE, Martyny JW, Miller JR, Cook M, Mangione EJ. Lead abSorption in indoor firing range users. Am J Public Health 1989;79: 1029-1032.
39. Armon C. Environmental risk factors for amyotrophic lateral sclerosis. Neuroepidemiology 2001;20:2-6.
40. Nelson LM. Epidemiology of ALS. Clin Neurosci 1996;3:327-331.
41. Mitchell JD. Amyotrophic lateral sclerosis: toxins and environment. Amyotroph Lateral Scler 2000;1:235-250.
42. Riggs JE. Trauma, axonal injury, and amyotrophic lateral sclerosis: a clinical correlate of a neuropharmacologic model. Clin Neuropharmacol 1995;18:273-276.
43. Cermelli C, Vinceti M, Beretti F, et al. Risk of sporadic amyotrophic lateral sclerosis associated with seropositivity for herpesviruses and echovirus-7. Eur J Epidemiol 2003;18:123-127.
44. Strickland D, Smith SA, Dolliff G, Goldman L, Roelofs RI. Physical activity, trauma, and ALS: a case-control study. Acta Neurol Scand 1996;94:45-50.
45. Longstreth WT, McGuire V, Koepsell TD, Wang Y, van Belle G. Risk of amyotrophic lateral sclerosis and history of physical activity: a population-based case-control study. Arch Neurol 1998;55:201-206.